Insider: Coleman Mark Director - Axsome Therapeutics, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 47,140 | 403,856 | 450,996 |
| Value | $7,943,325.70 | $68,051,755.28 | $75,995,080.98 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/26/2026 | DDS | 25,000 | Direct | COM | $161.11 | $4,027,750.00 | 47,140 |
| 09/08/2025 | AAP | 800 | Direct | COM | $127.20 | $101,760.00 | 47,437 |
| 09/08/2025 | AAP | 488 | Direct | COM | $127.40 | $62,171.20 | 48,212 |
| 09/08/2025 | AAP | 287 | Direct | COM | $127.30 | $36,535.10 | 47,724 |
| 05/28/2025 | DDS | 3,750 | Direct | COM | $103.43 | $387,862.50 | 46,637 |
| 05/27/2025 | DDS | 3,750 | Direct | COM | $105.47 | $395,512.50 | 50,387 |
| 05/20/2025 | DDS | 3,000 | Direct | COM | $107.49 | $322,473.00 | 54,137 |
| 05/29/2024 | DDS | 5,248 | Direct | COM | $75.14 | $394,332.62 | 14,600 |
| 05/28/2024 | DDS | 5,249 | Direct | COM | $75.21 | $394,774.67 | 19,848 |
| 09/15/2023 | DDS | 11,016 | Direct | COM | $75.19 | $828,241.26 | 25,097 |
| 09/15/2023 | DDS | 18,572 | Indirect | COM | $75.18 | $1,396,189.10 | 403,856 |
| 11/18/2021 | AAP | 1,021 | Indirect | COM | $35.10 | $35,837.10 | 422,428 |
| 11/18/2021 | AAP | 409 | Indirect | COM | $35.07 | $14,343.63 | 421,407 |
| 05/12/2021 | AAP | 500 | Indirect | COM | $58.15 | $29,075.00 | 420,998 |
| 06/29/2020 | AAP | 650 | Direct | COM | $78.50 | $51,025.00 | 403,698 |
| 06/26/2019 | AAP | 15,800 | Direct | COM | $23.10 | $364,980.00 | 668,848 |
| 06/25/2019 | AAP | 400 | Direct | COM | $23.25 | $9,300.00 | 653,048 |
| 05/13/2019 | AAP | 4,650 | Direct | COM | $21.44 | $99,696.00 | 652,648 |
| 03/19/2019 | AAP | 5,100 | Indirect | COM | $12.18 | $62,118.00 | 5,100 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2026 Zacks Investment Research